The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trial

[1]  Z. Massy,et al.  Calcimimetics increase CaSR expression and reduce mineralization in vascular smooth muscle cells: mechanisms of action. , 2014, Cardiovascular research.

[2]  D. Rodríguez‐Puyol,et al.  Regulation of endothelin-converting enzyme-1 (ECE-1) by the calcimimetic R-568. , 2013, Pharmacological research.

[3]  K. Mahaffey,et al.  Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. , 2012, The New England journal of medicine.

[4]  M. D. de Broe,et al.  Calcium-sensing receptor, calcimimetics, and cardiovascular calcifications in chronic kidney disease. , 2012, Kidney international.

[5]  J. Bonet,et al.  Cinacalcet may reduce arterial stiffness in patients with chronic renal disease and secondary hyperparathyroidism – Results of a small-scale, prospective, observational study , 2011 .

[6]  G. Mayer,et al.  Effect of Cinacalcet on Renal Electrolyte Handling and Systemic Arterial Blood Pressure in Kidney Transplant Patients With Persistent Hyperparathyroidism , 2011, Transplantation.

[7]  P. Raggi,et al.  The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  Tsutomu Inoue,et al.  Does cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism, improve arterial stiffness in patients on continuous ambulatory peritoneal dialysis? , 2011, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[9]  R. Agarwal.  Blood Pressure and Mortality Among Hemodialysis Patients , 2010, Hypertension.

[10]  K. Mahaffey,et al.  Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[11]  Eduardo Lacson,et al.  The epidemiology of systolic blood pressure and death risk in hemodialysis patients. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  E. Ritz,et al.  Acute blood pressure effects and chronic hypotensive action of calcimimetics in uremic rats. , 2006, Journal of the American Society of Nephrology : JASN.

[13]  J. Carr,et al.  Changes in cardiovascular calcification after parathyroidectomy in patients with ESRD. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  M. Safar,et al.  Stiffness of Capacitive and Conduit Arteries: Prognostic Significance for End-Stage Renal Disease Patients , 2005, Hypertension.

[15]  K. D. Workgroup.  K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  K. Drewnowska,et al.  Calcimimetic NPS R-568 induces hypotensive effect in spontaneously hypertensive rats. , 2005, American journal of hypertension.

[17]  B. C. Kwan,et al.  Improved health-related quality of life and left ventricular hypertrophy among dialysis patients treated with parathyroidectomy. , 2003, Journal of nephrology.

[18]  Nicole A. Lazar,et al.  Statistical Analysis With Missing Data , 2003, Technometrics.

[19]  J. Blacher,et al.  Aortic pulse wave velocity index and mortality in end-stage renal disease. , 2003, Kidney international.

[20]  S. Lewington.  Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360, pg 1903, 2002) , 2003 .

[21]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[22]  J. Almirall,et al.  Effect of Parathyroidectomy on Blood Pressure in Dialysis Patients , 2002, Nephron.

[23]  Roderick J. A. Little,et al.  Statistical Analysis with Missing Data: Little/Statistical Analysis with Missing Data , 2002 .

[24]  F. Taggi,et al.  Parathyroidectomy in Chronic Renal Failure: Short- and Long-Term Results on Parathyroid Function, Blood Pressure and Anemia , 2001, Nephron.

[25]  G. London,et al.  Arterial stiffening and vascular calcifications in end-stage renal disease. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  A. Levey,et al.  "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. , 1998, Kidney international.

[27]  E. Friedman,et al.  Parathyroidectomy Does Not Correct Hypertension in Patients on Maintenance Hemodialysis , 1998, American Journal of Nephrology.

[28]  D. Goldsmith,et al.  Blood pressure reduction after parathyroidectomy for secondary hyperparathyroidism: further evidence implicating calcium homeostasis in blood pressure regulation. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[29]  T. Drüeke,et al.  EFFECT OF PARATHYROIDECTOMY ON LEFT-VENTRICULAR FUNCTION IN HÆMODIALYSIS PATIENTS , 1980, The Lancet.